SCHEMBL13067255

SCHEMBL13067255

CCOCC(COC)(COC)COC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16076737 1.00
SCHEMBL12069856 1.00
SCHEMBL20911929 0.97
SCHEMBL14612047 0.89 THRB (0.34)
SCHEMBL1087735 0.87 ALDH1A1 (0.35)
SCHEMBL1087643 0.84 ALDH1A1 (0.33)
SCHEMBL12138334 0.84
SCHEMBL14577848 0.84 ALDH1A1 (0.33)
SCHEMBL9144749 0.84
SCHEMBL14671162 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020254612-A1 CONTROLLED-RELEASE TYROSINE KINASE INHIBITOR COMPOUNDS WITH LOCALIZED PD PROPERTIES Ascendis Pharma Oncology Division A/S (DK) 2020-12-24 WO disclosed
US-9267053-B2 Preparation and use of branched polymers containing hydroxyl and acrylate groups BASF SE (DE) 2016-02-23 US disclosed